Health Care

Doctors, Patients Seek Answers on Painkiller Risks

  • Playlist
  • Download
  • Embed
    <iframe src="" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

With sales of Cox-2 inhibitors declining, it's far from clear who would pay for the expensive safety studies needed to gather information on risks and safe dosages. hide caption

Expanded Chart: Declining Sales of Cox-2 Inhibitors
toggle caption

The FDA is weighing the safety of Celebrex, Bextra and Aleve in the wake of studies suggesting this class of drugs, known as Cox-2 inhibitors, may be dangerous. But some patients say they aren't getting enough pain relief without the drugs. Doctors want more studies to help define who's at risk and what's a safe dose.



Please keep your community civil. All comments must follow the Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

NPR thanks our sponsors

Become an NPR sponsor

Support comes from